Physical Therapists Identifying Patients With Opioid Misuse

August 2, 2023 updated by: Jake Magel, University of Utah
The purpose of this study is to develop and operationalize key procedures for physical therapists (n = 12) to address patients who are at risk for or have opioid misuse (OM). The investigators will train physical therapists in procedures to: 1) engage patients at risk for OM in conversations about appropriate opioid use, 2) screen and 3) assess these patients for OM and, 4) refer patients for further treatment if OM is suspected. The investigators will employ a modified Delphi approach to iteratively refine and operationalize the procedures and to arrive at a finalized procedure manual followed by an evaluation of the implementation of these procedures.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The purpose of this study is to develop and operationalize key procedures for physical therapists (n = 12) to address patients who are at risk for or have OM. The investigators will train physical therapists in procedures to: 1) engage patients at risk for OM in conversations about appropriate opioid use, 2) screen and 3) assess these patients for OM and, 4) refer patients for further treatment if OM is suspected. The investigators will employ a modified Delphi approach to iteratively refine and operationalize the procedures and to arrive at a finalized procedure manual followed by an evaluation of the implementation of these procedures. Approximately 4 months following the development of the manual and the distribution of the finalized manual, the investigators will conduct semi-structured interviews to determine the barriers and facilitators to implementing the procedures learned in the training.

Our aims are:

  1. Qualitatively evaluate physical therapists' perceptions and recommendations for implementing OM procedures.
  2. Evaluate the implementation of the manualized OM procedures.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84108
        • University of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • University of Utah physical therapists with at least 0.5 full-time equivalent
  • Self report managing patients with musculoskeletal pain

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training Arm
The training will be composed of 4 separate training sessions provided every 2 - 4 weeks. During the 1st session (45 minutes), the investigators will educate the physical therapist about the different categories of opioid use including opioid misuse (OM) and the risks associated with OM as well as training to engage the patient in a conversation about opioid use. The 2nd and 3rd sessions (30 minutes each) involve training in procedures to screen and assess patients at risk for OM, respectively. The 4th session (30 minutes) involves training in procedures to refer patients to a specialist or a primary care provider for further treatment if OM is suspected.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Drug and Drug Problems Perception Questionnaire (DDPPQ)
Time Frame: Baseline, immediate post training, 4 months after last training session
The DDPPQ is a 20 item tool used to measure the attitudes of health care providers related to the management of patients misusing drugs and contains 5 subscales (Role Adequacy: 7 items; Role Legitimacy: 2 items; Role Support: 3 items; Role Self-esteem: 4 items; Job Satisfaction: 4 items) Each item is scored on a 7-point scale (1 = strongly agree to 7 = strongly disagree). Each item was modified to asses the health care providers' attitudes about managing patients with opioid misuse.
Baseline, immediate post training, 4 months after last training session

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thematic analysis from semi-structured interviews
Time Frame: 4 months after the last training session
Semi-structured interviews to assess barriers and facilitators of implementing the procedures learned in the training
4 months after the last training session
Reach
Time Frame: Immediate post training
Proportion of physical therapists who agreed to attend the training that attended all training sessions
Immediate post training
Adoption 1- engaging patients in conversations
Time Frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report engaging patients in conversations about opioid misuse,
Approximately 4 months after last training session
Adoption 2 - screening
Time Frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report screening for opioid misuse
Approximately 4 months after last training session
Adoption 3 - assessing
Time Frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report assessing patients for opioid misuse
Approximately 4 months after last training session
Adoption 4 - referring
Time Frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report referring for opioid misuse
Approximately 4 months after last training session
Qualitative thematic analysis of each focus group
Time Frame: Immediately after each of the 4 training sessions.
The investigators will conduct focus groups after each training session. All sessions will be analyzed together to qualitatively assess the physical therapists' receptivity to the procedures learned in the training sessions.
Immediately after each of the 4 training sessions.
Change in the Frequency of opioid misuse management practices - Adapted from the Alcohol Education Survey
Time Frame: Baseline, immediately post training and to approximately 4 months after the last training session
Questions were adapted: "How often do you ask patients about alcohol problems?" was modified to: "How often do you ask patients about problems with prescription opioid medication misuse? 4 additional questions were similarly modified ([1] How often do you formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [2] How often do you assess patients' readiness to change their prescription opioid medication misuse behaviors?; [3] How often do you discuss/advise patients to change their prescription opioid medication misuse behaviors?; [4] How often do you refer patients with prescription opioid medication misuse for further assessments or interventions?). Scoring: Never, Rarely (less than 10% of the time), Occasionally (about 30% of the time), Sometimes (about 50% of the time), Frequently (about 70% of the time), Usually (about 90% of the time), Every time.
Baseline, immediately post training and to approximately 4 months after the last training session
Manual of procedures
Time Frame: Approximately 4 months after the last training session.
At the end of the study after the individual interviews, the investigators will finalize the manual of opioid misuse procedures for physical therapists.
Approximately 4 months after the last training session.
Change in the Confidence in opioid misuse management practices. Adapted from the Alcohol Education Survey
Time Frame: Baseline, immediately post training and to approximately 4 months after the last training session
These questions were adapted from a survey developed to improve health care providers' management of patients with alcohol problems. The questions are: ([1] I am confident in my ability to ask patients about prescription opioid medication misuse, [2] I am confident in my ability to formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [3] I am confident in my ability to assess patients' readiness to change their prescription opioid medication misuse behaviors; [4] I am confident in my ability to discuss/advise patients to change their prescription opioid medication misuse behaviors; [5] I am confident in my ability to refer patients with prescription opioid medication misuse for further assessments or interventions?). Each confidence with management practice question was scored on a 7-point Likert scale (1 = no confidence; 7 = high confidence).
Baseline, immediately post training and to approximately 4 months after the last training session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Magel, PhD, University of Utah

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2022

Primary Completion (Actual)

May 27, 2023

Study Completion (Actual)

June 8, 2023

Study Registration Dates

First Submitted

August 3, 2022

First Submitted That Met QC Criteria

August 9, 2022

First Posted (Actual)

August 11, 2022

Study Record Updates

Last Update Posted (Actual)

August 4, 2023

Last Update Submitted That Met QC Criteria

August 2, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data to be shared: Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

What documents will be available: Study protocol, statistical analysis plan, Analytic code.

With whom will the data be shared: Researchers who provide a methodologically sound proposal

For what type of analyses: To achieve the aims in approved proposal

IPD Sharing Time Frame

Beginning 9 months and ending 36 months following article publication

IPD Sharing Access Criteria

By what mechanism will data be made available: Proposal should be directed to Jake.Magel@hsc.utah.edu to gain access, data requestors will need to sign a data access agreement. Link to data will be provided.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Training Arm

3
Subscribe